which is a major risk factor for Cardiovascular Disease (CVD) research hub

A Phase IIb, Multicenter, Randomized, Parallel-group, Double- blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AZD0780 in Participants with Dyslipidemia

This study looks at a new medicine called AZD0780 for people with high cholesterol. We want to see if it safely lowers bad cholesterol and other fats in the blood, which can help prevent heart problems. Participants will take the medicine or a dummy pill.